TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES.
about
Group B Streptococcus vaccine: state of the artGroup B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesInitial studies of the molecular basis of peptide mimicry of group B streptococcal type III capsular polysaccharide.Identification of a group B streptococcal fibronectin binding protein, SfbA, that contributes to invasion of brain endothelium and development of meningitis.Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.Regulation of cell component production by growth rate in the group B Streptococcus.TYPE-SPECIFIC ANTIGENS, M AND T, OF MATT AND GLOSSY VARIANTS OF GROUP A HEMOLYTIC STREPTOCOCCIPrevention of group B streptococcal neonatal disease revisited. The DEVANI European project.Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III.Immunochemical studies on the group and type antigens of group F streptococci and the identification of a grouplike carbohydrate in a type II strain with an undesignated group antigen.Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide.Immunodeterminant specificity of human immunity to type III group B streptococcusMultiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigensImmunochemical characterization of the "native" type III polysaccharide of group B Streptococcus.Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.The streptolysins of various groups and types of haemolytic streptococci; a serological investigationCorrelation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.Group B Streptococcus: global incidence and vaccine development.Neonatal streptococcal infections.Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.Prevention of neonatal group B streptococcal disease.An update on vaccination against group B streptococcus.Strategies to develop vaccines of pediatric interest.Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease.Type-specific polysaccharide antigens of group B streptococciGroup B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.Human and bovine group B streptococci: two distinct populations.
P2860
Q26796438-E683FB22-D478-4D7E-BFC0-7520337F2943Q28075884-C829EEEF-44CB-4720-B9EB-33A56363AE6BQ30677678-F2744C66-1D41-49C4-A01A-1E391E3EE54CQ33603050-606423D6-7687-40B0-A056-6C136CECAB4FQ33715970-ADC74AF5-EBF2-46CA-95B0-794A19EBD84FQ33992857-6E320722-8A59-4A70-A387-0D4C64464501Q34019948-274AAE25-CACD-4996-92BA-1EC5D05C4E40Q34252808-2982879F-34AE-4C1B-B29F-C8AF076AE062Q35093878-45DA36D0-7ADC-438C-B164-9C28269F3069Q36055121-7F29D413-C1B2-4769-9E59-30F327F0A3ECQ36268419-F4560C82-C81A-43B6-931D-909800A92AF8Q36332961-70D5935C-4C2C-481D-8907-C2DD19BB0FF8Q36341232-B88B627C-4515-49BD-BCAF-3C2DA11A94EFQ36358253-BAE20296-6DDE-4070-A858-A95354147FEDQ36359029-B768753E-F133-4503-85B1-23C2F3A8B253Q36359342-39B3A9B2-B99A-42A2-8E55-BE0E7DC64CAEQ36381996-80DB672E-7BDA-437B-A569-CC21AAD9B54AQ36430428-6A5FFCD9-4D1C-4B4E-8DA6-6AA64181D65BQ36646803-9E86F775-A198-451A-A411-CBC51F29E078Q36812283-DDB5B734-50DA-49C1-B9EC-B5841A5B39FBQ37007743-6B193F68-EBA3-437C-82E4-0626C4AF6F95Q37359329-963F3449-6B43-400D-B2DE-E8086CC91661Q37878487-3A065226-2DD2-4077-A13B-94766475E7AFQ38819027-1CBB15DC-105C-42EE-95E1-D95ABB500CC2Q38844623-16F39064-3E6D-4564-A153-822D5AA79834Q41808964-38405084-A876-4D3B-9D4A-EC58AB7B32D2Q52624533-459D6B75-5110-4F9E-8FF0-394CFAE0B86AQ54467960-9E93AC5E-ED02-4A9F-B61E-EECCCC34A0E0
P2860
TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES.
description
1938 nî lūn-bûn
@nan
1938年の論文
@ja
1938年論文
@yue
1938年論文
@zh-hant
1938年論文
@zh-hk
1938年論文
@zh-mo
1938年論文
@zh-tw
1938年论文
@wuu
1938年论文
@zh
1938年论文
@zh-cn
name
TWO SEROLOGICAL TYPES OF GROUP ...... CAL, TYPE-SPECIFIC SUBSTANCES.
@en
TWO SEROLOGICAL TYPES OF GROUP ...... CAL, TYPE-SPECIFIC SUBSTANCES.
@nl
type
label
TWO SEROLOGICAL TYPES OF GROUP ...... CAL, TYPE-SPECIFIC SUBSTANCES.
@en
TWO SEROLOGICAL TYPES OF GROUP ...... CAL, TYPE-SPECIFIC SUBSTANCES.
@nl
prefLabel
TWO SEROLOGICAL TYPES OF GROUP ...... CAL, TYPE-SPECIFIC SUBSTANCES.
@en
TWO SEROLOGICAL TYPES OF GROUP ...... CAL, TYPE-SPECIFIC SUBSTANCES.
@nl
P2860
P356
P1476
TWO SEROLOGICAL TYPES OF GROUP ...... CAL, TYPE-SPECIFIC SUBSTANCES.
@en
P2093
Lancefield RC
P2860
P356
10.1084/JEM.67.1.25
P407
P577
1938-01-01T00:00:00Z